Wolverine Trading, LLC Boston Scientific Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $890,111 - $1.02 Million	12,200 Added 6.42%	202,100 $16.9 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $7.22 Million - $8.33 Million	107,200 Added 129.63%	189,900 $14.6 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $259,200 - $308,790	4,500 Added 5.75%	82,700 $5.66 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $379,392 - $450,918	-7,800 Reduced 9.07%	78,200 $4.52 Million
Q3 2023 Nov 15, 2023	BUY	$50.19 - $54.68 $1.03 Million - $1.12 Million	20,500 Added 31.3%	86,000 $4.54 Million
Q2 2023 Aug 23, 2023	SELL	$49.72 - $54.64 $989,428 - $1.09 Million	-19,900 Reduced 23.3%	65,500 $3.54 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $1.78 Million - $1.98 Million	-39,500 Reduced 31.63%	85,400 $4.24 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $1.25 Million - $1.49 Million	-31,500 Reduced 20.14%	124,900 $5.78 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1.95 Million - $5.81 Million	-53,000 Reduced 25.31%	156,400 $6.15 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $2.88 Million - $3.85 Million	81,800 Added 64.11%	209,400 $7.92 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $1.02 Million - $1.12 Million	-24,900 Reduced 16.33%	127,600 $5.7 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $1.09 Million - $1.28 Million	-28,600 Reduced 15.79%	152,500 $6.56 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $1.13 Million - $1.25 Million	27,300 Added 17.75%	181,100 $7.95 Million
Q2 2021 Aug 06, 2021	BUY	$38.58 - $44.24 $2.06 Million - $2.36 Million	53,300 Added 53.03%	153,800 $6.65 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $3.16 Million - $3.55 Million	-89,500 Reduced 47.11%	100,500 $3.92 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $6.3 Million - $7.97 Million	190,000 New	190,000 $6.76 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $2.82 Million - $3.46 Million	-82,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $803,054 - $1.04 Million	-26,600 Reduced 24.49%	82,000 $2.84 Million
Q1 2020 May 11, 2020	SELL	$25.83 - $45.71 $741,321 - $1.31 Million	-28,700 Reduced 20.9%	108,600 $3.44 Million
Q4 2019 Feb 12, 2020	SELL	$37.87 - $45.37 $306,747 - $367,497	-8,100 Reduced 5.57%	137,300 $6.18 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $5.86 Million - $6.32 Million	145,400 New	145,400 $5.86 Million
Q2 2019 Aug 20, 2019	SELL	$34.91 - $42.98 $5.68 Million - $7 Million	-162,800 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $16,455 - $20,375	-500 Reduced 0.31%	162,800 $6.25 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $5.06 Million - $6.23 Million	-159,500 Reduced 49.41%	163,300 $5.66 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $6.13 Million - $7.22 Million	186,800 Added 137.35%	322,800 $12.4 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $488,880 - $553,676	19,400 Added 16.64%	136,000 $3.72 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $823,028 - $989,360	33,200 Added 39.81%	116,600 $2.89 Million
Q3 2017 Nov 15, 2017	BUY	$26.26 - $29.17 $2.19 Million - $2.43 Million	83,400	83,400 $2.43 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$12 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11.5 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.74 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.45 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$3 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $131B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account